Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Biomed Research International
Volume 2017, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2017-02-24
DOI
10.1155/2017/9729107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
- (2015) Mei Yang et al. PLoS One
- Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease
- (2014) David E. Amacher BIOMARKERS
- Diagnostic Accuracy Measures
- (2014) Paolo Eusebi CEREBROVASCULAR DISEASES
- Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients
- (2014) Alexander Wree et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
- (2013) R. Kwok et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
- (2013) Yun Shen et al. Cardiovascular Diabetology
- Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis
- (2013) Jing Chen et al. HEPATOLOGY RESEARCH
- Circulating Levels of FGF-21 in Obese Youth: Associations With Liver Fat Content and Markers of Liver Damage
- (2013) Cosimo Giannini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
- (2013) Alexander Wree et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease
- (2013) Anna Alisi et al. PLoS One
- Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses
- (2013) Nikola Panic et al. PLoS One
- Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers
- (2012) J. Shen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis
- (2012) Yusuf Yilmaz et al. CLINICA CHIMICA ACTA
- Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives
- (2012) Y. C. Woo et al. CLINICAL ENDOCRINOLOGY
- Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
- (2012) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
- (2012) Jiayun Shen et al. JOURNAL OF HEPATOLOGY
- High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China
- (2012) Huating Li et al. JOURNAL OF HEPATOLOGY
- Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
- (2011) H. Yu et al. CLINICAL CHEMISTRY
- Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis
- (2011) Srinivasan Dasarathy et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis
- (2011) Diana Joka et al. HEPATOLOGY
- Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
- (2011) Hongmei Yan et al. PLoS One
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes
- (2010) Alexander Wree et al. DIGESTION
- Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
- (2010) Yusuf Yilmaz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
- (2010) Judith Ertle et al. INTERNATIONAL JOURNAL OF CANCER
- Serum Apoptotic Caspase Activity in Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease
- (2010) George V. Papatheodoridis et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis
- (2010) Pamela Valva et al. JOURNAL OF MEDICAL VIROLOGY
- A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
- (2010) Zobair M. Younossi et al. OBESITY SURGERY
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
- (2009) Elisa Fabbrini et al. HEPATOLOGY
- Noninvasive assessment of liver disease severity with liver fat score and CK-18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation
- (2009) Giovanni Musso et al. HEPATOLOGY
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease
- (2009) Raza Malik et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients
- (2008) Dima L. Diab et al. Clinical Gastroenterology and Hepatology
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- A “Biomarker Biopsy” for the Diagnosis of NASH: Promises from CK-18 Fragments
- (2008) Yusuf Yilmaz et al. OBESITY SURGERY
- A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
- (2008) Zobair M. Younossi et al. OBESITY SURGERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now